Author

Grace Langford

Observed name: G. Langford

Institutions: Velindre NHS Trust, Velindre Cancer Centre

Observed institutions: Velindre NHS Trust, University Hospital of Wales, Velindre Cancer Centre

ORCID: 0000-0002-5420-7360

Observed ORCID: 0000-0002-5420-7360

OpenAlex ID: A5091305189

Tolerability, dose modification, and treatment compliance with adjuvant abemaciclib in high-risk early breast cancer: a UK real-world multicentre study (CONCISE)

2026 · H. Abdallah, Y. Owoseni, et al. · ESMO Real World Data and Digital Oncology

Real-Life Outcomes of First-Line Palliative Chemoimmunotherapy in Oesophago-Gastric Cancers: A Multi-Centre Retrospective Cohort Study

2026 · James Birch-Ford, Ben Crosby, et al. · Cancers

Abstract PS3-09-13: Adjuvant Abemaciclib in Male Breast Cancer: A UK Multicentre Case Series from the CONCISE Study

2026 · A. Ghose, H. Abdallah, et al. · Clinical Cancer Research

Abstract PS2-02-12: Tolerability of Adjuvant Abemaciclib in Older Adults with High-Risk Early Breast Cancer: Multicentre UK Real-World Data from the CONCISE Study

2026 · H. Abdallah, O. Ayodele, et al. · Clinical Cancer Research

Abstract PS3-07-12: The CONCISE Study : A Pan-UK Real-World Audit of Adjuvant Abemaciclib Use in High-Risk Early Breast Cancer

2026 · B. Baraka, A. Ghose, et al. · Clinical Cancer Research

2023 · Grace Langford · Practical Neurology

Works count: 6

Citation count:

H-index:

I10-index: